(7-(4-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy}butoxy-d8)-3,4-dihydroquinolin-2(1H)-one)
| Product Name |
(7-(4-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy}butoxy-d8)-3,4-dihydroquinolin-2(1H)-one)
|
| Product Code |
DA-A298-31
|
| Chemical name |
(7-(4-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy}butoxy-d8)-3,4-dihydroquinolin-2(1H)-one)
|
| Synonyms |
7-(4-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)butoxy-1,1,2,2,3,3,4,4-d8)-3,4-dihydroquinolin-2(1H)-one;
|
| Impurity |
NA
|
| CAS Number |
2733861-22-6
|
| Alternate CAS # |
NA
|
| Molecular form |
C27H27D8Cl2N3O3
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
528.54
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
intermediates,heterocycles,impurities,pharmaceutical standards,Fine Chemicals,neurochemicals,stable isotopes
|
| Boiling Point |
NA
|
| Applications |
(7-(4-{4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy}butoxy-d8)-3,4-dihydroquinolin-2(1H)-one) is a labelled impurity of Aripiprazole, a selective dopamine D2-receptor antagonist with dopamine autoreceptor agonist activity.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
